Concepedia

Masayo Oishi

MO

Statistics

Publications

5

Citations

137

H-Index

5

Active since

2010

Affiliations

Pfizer (United States)(Current)

Keio University

Pfizer (Japan)

Masayo Oishi is an author at Pfizer (United States) specializing in pharmacology, pharmacokinetics, and pharmacokinetic modeling.

ORCID

Publications per year

2010–2024

5

Publications

5

Population Pharmacokinetics of Apixaban in Subjects With Nonvalvular Atrial Fibrillation

Brenda Cirincione, Kenneth G. Kowalski, Jace Nielsen et al. · CPT Pharmacometrics & Systems Pharmacology · 2018 · 72 citations · Full text

, , +16

Modeling of Blood–Brain Barrier (BBB) Dysfunction and Immune Cell Migration Using Human BBB-on-a-Chip for Drug Discovery Research

Masato Ohbuchi, Mayu Shibuta, Kazuhiro Tetsuka et al. · International Journal of Molecular Sciences · 2024 · 26 citations · Full text

, , +15

Effect of the CYP2D6*10 Genotype on Tolterodine Pharmacokinetics

Masayo Oishi, Kōji Chiba, Bimal Malhotra et al. · Drug Metabolism and Disposition · 2010 · 15 citations

, , +14

A Comparison of the Pharmacokinetics and Drug Safety Among East Asian Populations

Masayo Oishi, Shintaro Hiro, Nobushige Matsuoka et al. · Therapeutic Innovation & Regulatory Science · 2014 · 13 citations

, , +12

Pharmacokinetics of Tolterodine in Japanese and Koreans: Physiological and Stochastic Assessment of Ethnic Differences

Masayo Oishi, Kōji Chiba, Bimal Malhotra et al. · Drug Metabolism and Pharmacokinetics · 2011 · 11 citations

, , +9

1–5 of 5